These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adverse ocular reactions possibly associated with isotretinoin. Fraunfelder FT; LaBraico JM; Meyer SM Am J Ophthalmol; 1985 Oct; 100(4):534-7. PubMed ID: 2931989 [TBL] [Abstract][Full Text] [Related]
4. Another threat to the availability of isotretinoin: ocular side effects have aviation authorities considering restricting use from (even potential) pilots. Burkhart CG Dermatol Online J; 2008 Jul; 14(7):2. PubMed ID: 18718186 [TBL] [Abstract][Full Text] [Related]
6. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin. Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405 [TBL] [Abstract][Full Text] [Related]
7. Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects. Fraunfelder FW; Fraunfelder FT Ophthalmology; 2004 Jul; 111(7):1275-9. PubMed ID: 15234126 [TBL] [Abstract][Full Text] [Related]
8. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System. Stobaugh DJ; Deepak P; Ehrenpreis ED J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730 [TBL] [Abstract][Full Text] [Related]
10. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Bozkurt B; Irkeç MT; Atakan N; Orhan M; Geyik PO Eur J Ophthalmol; 2002; 12(3):173-6. PubMed ID: 12113560 [TBL] [Abstract][Full Text] [Related]
13. Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment. Caglar C; Senel E; Sabancilar E; Durmus M Int Ophthalmol; 2017 Feb; 37(1):197-202. PubMed ID: 27193123 [TBL] [Abstract][Full Text] [Related]
14. Premacular hemorrhage due to isotretinoin use. Onder HI; Turan H; Kilic AC; Kaya M; Tunc M Cutan Ocul Toxicol; 2013 Jun; 32(2):170-2. PubMed ID: 22510043 [TBL] [Abstract][Full Text] [Related]
15. Ocular side effects from herbal medicines and nutritional supplements. Fraunfelder FW Am J Ophthalmol; 2004 Oct; 138(4):639-47. PubMed ID: 15488795 [TBL] [Abstract][Full Text] [Related]
16. [Isotretinoin administration in treatment of acne vulgaris. A prospective study of the kind and extent of ocular complications]. Egger SF; Huber-Spitzy V; Böhler K; Scholda C Ophthalmologe; 1995 Feb; 92(1):17-20. PubMed ID: 7719068 [TBL] [Abstract][Full Text] [Related]
17. Ocular adverse effects of systemic treatment with isotretinoin. Neudorfer M; Goldshtein I; Shamai-Lubovitz O; Chodick G; Dadon Y; Shalev V Arch Dermatol; 2012 Jul; 148(7):803-8. PubMed ID: 22508771 [TBL] [Abstract][Full Text] [Related]
18. Dermatologists' Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt. Elshafie M; Srour A; El-Ansarey H; Abdel-Kader M; Kabbash I; Mashaly M Clin Cosmet Investig Dermatol; 2021; 14():1295-1301. PubMed ID: 34566419 [TBL] [Abstract][Full Text] [Related]
19. Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin. Scheinfeld N; Bangalore S J Drugs Dermatol; 2006 May; 5(5):467-8. PubMed ID: 16703787 [TBL] [Abstract][Full Text] [Related]
20. Giant cobblestone-like papillae during isotretinoin therapy. Rosen E; Raz J; Segev F Ocul Immunol Inflamm; 2009; 17(5):312-3. PubMed ID: 19831559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]